(Q37701301)

22 August 2017

1 reference

title

Aspects of TNF inhibitor therapy in rheumatoid arthritis (English)

1 reference

22 August 2017

0 references

1 reference

2

Paul Emery

0 references

author name string

Jackie Nam

series ordinal

1

1 reference

22 August 2017

publication date

2 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

20

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

325-330

1 reference

Treating very early rheumatoid arthritis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0277-7

10.3109/S10165-010-0277-7

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference